What question did this study set out to answer?

To explore the potential of Mincle ligands as next-generation vaccine adjuvants targeting intracellular pathogens.

Lessons from mycobacteria: development and design of Mincle-targeting adjuvants

View Full Paper

Ask AI

Bookmark

Authors

This review highlights Mincle-targeting adjuvants to improve vaccine responses in humans, suggesting their potential effectiveness.

To explore the potential of Mincle ligands as next-generation vaccine adjuvants targeting intracellular pathogens.
Review of C-type lectin receptors and their role in immunity
Analysis of Mincle's ligand recognition mechanisms
Discussion of synthesizable Mincle ligands and their immunostimulatory properties
Evaluation of novel dual-ligand adjuvant strategies and delivery systems
Mincle promotes Th1 and Th17 immune responses essential for fighting intracellular pathogens.
Trehalose dibehenate and lipidated brartemicin are promising candidates for Mincle ligands.
Dual-ligand systems show enhanced immunostimulatory potential.
Species-specific efficacy must be considered for clinical applications.

Ishizuka et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark